Literature DB >> 28215663

Interleukin-6 inhibition for rheumatoid arthritis.

Roy Fleischmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28215663     DOI： 10.1016/S0140-6736(17)30405-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  High mobility group box protein 1 downregulates acid β-glucosidase 1 in synovial fibroblasts from patients with rheumatoid arthritis.

Authors:  Bin Zhang; Hongzhi Wang; Yiwen Wang; Mingfeng Yang; Juanfang Gu; Ming Yao
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

2.  Serum cytokines to predict systemic lupus erythematosus clinical and serological activity.

Authors:  Victor Moreno-Torres; Raquel Castejón; María Martínez-Urbistondo; Ángela Gutiérrez-Rojas; Jose Vázquez-Comendador; Pablo Tutor; Pedro Durán-Del Campo; Susana Mellor-Pita; Silvia Rosado; Juan-Antonio Vargas-Núñez
Journal:  Clin Transl Sci       Date:  2022-05-04       Impact factor: 4.438

Review 3.  Signals from the Niche: Insights into the Role of IGF-1 and IL-6 in Modulating Skeletal Muscle Fibrosis.

Authors:  Laura Forcina; Carmen Miano; Bianca Maria Scicchitano; Antonio Musarò
Journal:  Cells       Date:  2019-03-11       Impact factor: 6.600

4.  Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19.

Authors:  Lucy Ck Bell; Cem Meydan; Jacob Kim; Jonathan Foox; Daniel Butler; Christopher E Mason; Sagi D Shapira; Mahdad Noursadeghi; Gabriele Pollara
Journal:  bioRxiv       Date:  2020-12-03

5.  Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19.

Authors:  Lucy C K Bell; Cem Meydan; Jacob Kim; Jonathan Foox; Daniel Butler; Christopher E Mason; Sagi D Shapira; Mahdad Noursadeghi; Gabriele Pollara
Journal:  iScience       Date:  2020-12-07

6.  Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology.

Authors:  Chuan Liu; Fangfang Fan; Lu Zhong; Jinsong Su; Yi Zhang; Ya Tu
Journal:  PLoS One       Date:  2022-02-07       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.